CASI Pharmaceuticals
CASI
CASI
24 hedge funds and large institutions have $5.17M invested in CASI Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$87K | |
| 2 | +$29K | |
| 3 | +$27K | |
| 4 |
WSCM
Wellington Shields Capital Management
New York
|
+$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$8K |
Top Sellers
| 1 | -$378K | |
| 2 | -$127K | |
| 3 | -$90K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$46K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$43.8K |